Cargando…
Autoantibodies to hnRNP-A2 in SLE: identification of disease-specific linear epitopes and correlation with disease activity and clinical features
Autores principales: | Schett, G, Monneaux, F, Hoefler, E, Fritsch, R, Tohidast-Akrad, M, Smolen, J, Muller, S, Steiner, G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833592/ http://dx.doi.org/10.1186/ar655 |
Ejemplares similares
-
Overexpression of the autoantigen hnRNP-A2 (RA33), the tumour suppressor p53 and activated MAP-Kinase p38 in inflamed synovial tissue
por: Hayer, S, et al.
Publicado: (2002) -
Identification of hnRNP-A2 (RA33) as a major B-cell and T-cell autoantigen in pristane–induced arthritis
por: Hoffmann, MH, et al.
Publicado: (2005) -
Aberrant expression of the autoantigen hnRNP-A2/RA33 in the joints of patients with rheumatoid arthritis and TNF-alpha transgenic mice: a clue to autoimmunity?
por: Hayer, S, et al.
Publicado: (2001) -
Characterization of RA33 (hnRNP-A2/B1)-autoreactive T cells in SLE-patients
por: Fritsch, R, et al.
Publicado: (2001) -
Autoantibodies to the mRNA destabilizing protein hnRNP-D/AUF1 in patients with systemic autoimmune diseases
por: Skriner, K, et al.
Publicado: (2001)